United Kingdom · Question · Written question
UIN 73656
Prostate Cancer: Hormone Treatments
Original
Introduced
1 September 2025
Last action
19 September 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 September 2025
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2025 to Question 64681 on Prostate Cancer: Hormone Treatments, for what reason recurrent headroom in revenue budgets is considered a barrier to implementing the abi
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 September 2025
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2025 to Question 64681 on Prostate Cancer: Hormone Treatments, for what reason recurrent headroom in revenue budgets is considered a barrier to implementing the abi
Source: Commons
19 September 2025
Answer
Reimbursement of abiraterone across all indications is managed at a national level by NHS England who must ensure the affordability of introducing any new routine commissioning policies, alongside maintaining existing services for patients and meeting the...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-01/73656
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1830438
- uk · wq-1830438 · source updated 19 September 2025